Self monitoring of blood glucose levels helps patients with diabetesOctober 02, 2009Self-monitoring of blood glucose (SMBG) enables those with diabetes to modify their behavior, adjust their medicine and understand their disease to better manage it, according to a recent study, published by SAGE in The Diabetes Educator. The research looked at "paired testing," a self-monitored testing both before and after specific events, to evaluate whether it could assist the patient in making better health and food choice decisions over time. In the study, sponsored by Roche Diagnostics through an unrestricted educational grant, healthcare professionals from various medical specialties collaborated to review current research regarding the value and utility of SMBG and formulate professional opinions regarding its use. With the goal of encouraging patients' active involvement in the control of their own disease, instead of just blindly following the edicts of their healthcare providers, researchers found that paired testing can be helpful to: * provide immediate feedback regarding the impact of specific eating and exercise actions * assess critical nuances of the disease to help the patient make the very best choices * target specific meals to identify the impact of food choices on blood glucose levels * detect differences between weekend and weekday schedules and habits * learn what does and what does not work in the daily management of diabetes * facilitate positive and healthy patient self-care behaviors "Although the utility of SMBG in non-insulin-treated Type 2 diabetes remains controversial," write the authors in the article, "a recent report from the International Diabetes Federation recommends SMBG use in this population if it is used to educate/motivate individuals and/or monitor and adjust therapy. Healthcare providers must develop strategies to utilize SMBG in ways that address these criteria." SAGE Publications |
|||||||||||||||||||||
| Related Blood Glucose Current Events and Blood Glucose News Articles Researchers discover mechanism of insulin production that can lead to better treatment for diabetes How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universities. A decade later, lifestyle changes or metformin still lower type 2 diabetes risk Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent compared with placebo in people at high risk for the disease, researchers conclude based on 10 years of data. Should children undergo surgery without a long period of fasting after feeding? Blood glucose levels in a lot of patients fed normal liquid food (NLF) and a high calorie diet (HCD) were high. URI nutritionist finds chewing gum can reduce calorie intake, increase energy expenditure A nutrition professor at the University of Rhode Island studying the effects of chewing sugar-free gum on weight management has found that it can help to reduce calorie intake and increase energy expenditure. Hunting for the Prozac Gene Prozac works wonders for some depressed people, but not for others. In some cases, patients derive little benefit and at worst, it can lead to bizarre hallucinations and fits of rage. Healthy neighborhoods may be associated with lower diabetes risk Individuals living in neighborhoods conducive to physical activity and providing access to healthy foods may have a lower risk of developing type 2 diabetes in a five-year period, according to a report in the October 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. CHEO RI study uses sophisticated genetic engineering to improve insulin-producing beta cells One of the biggest mysteries about diabetes is why specialized cells in the pancreas stop secreting insulin, which the body needs in order to store glucose from food. Self-monitoring of blood glucose Diabetes patients should always control their own blood sugar values if this leads to improvements in their treatment. Is inhaled insulin delivery still a possibility? Why has it been a commercial failure? The commercial failure of Exubera® (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Postmenopausal women benefit from endurance training as much as younger women Marilyn Graham was 56 when she signed up for a grueling hour of cycling each morning for 12 weeks, occasionally decked out in a mask, a heart monitor and a bag of intravenous fluid and subjected to needle pricks to obtain blood samples. More Blood Glucose Current Events and Blood Glucose News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||